Disc Medicine Lands Million: Investors React to FDA Catalyst
A private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
Discover why dividend ETFs incur fees, including management costs and tracking errors, and how those charges influence your long-term results.
26,393 articlesA private equity firm just disclosed a sizable stake in Disc Medicine, signaling growing confidence in its red blood ...
Markets have celebrated a long rally, but chair nominee kevin warsh's real test may lie in credibility, independence,...
USA Rare Earth's stock dropped 15.7% in February as broad markets wobbled, but March brought signs of life. This guid...
The U.S. DOJ moves to retry Tornado Cash developer Roman Storm on key charges in SDNY, aiming to resolve unresolved c...
A rising fintech stock year story shows profits climbing while a major fund trims nearly $300M from its stake. The mo...
Privacy-preserving crypto tools are meeting a hard policy edge. This article unpacks why developers feel at risk, wha...
Take a practical tour of arcutis (arqt) 2026 earnings, from revenue mix and margins to pipeline progress and risk fac...
PropLogix launches PropOptix, a sales outreach platform that uses real-time market signals to connect title firms wit...
Sumitomo Forestry has completed its $4.5 billion acquisition of Tri Pointe Homes, moving the combined group into the ...
A 71-year-old widower inherits his late wife’s $890,000 IRA and faces a pivotal choice. Tax experts warn that a singl...
Lockup terms can shape the first days of a stock's life after an IPO. This guide explains standard practices, what an...
A tectonic shift is quietly unfolding in mobility and AI. The trillion robotaxi boom real could power a new era of ea...